Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients

This study has been completed.
Information provided by:
Progenics Pharmaceuticals, Inc. Identifier:
First received: February 20, 2003
Last updated: October 2, 2008
Last verified: October 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2005
  Estimated Primary Completion Date: No date given